GRISEOFULVIN for Tinea capitis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 12 adverse event reports in the FDA FAERS database where GRISEOFULVIN was used for Tinea capitis.
Most Reported Side Effects for GRISEOFULVIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 23 | 17.4% | 0 | 2 |
| Drug reaction with eosinophilia and systemic symptoms | 13 | 9.9% | 0 | 12 |
| Drug resistance | 9 | 6.8% | 0 | 0 |
| Drug hypersensitivity | 8 | 6.1% | 0 | 0 |
| Erythema multiforme | 7 | 5.3% | 0 | 7 |
| Linear iga disease | 7 | 5.3% | 0 | 7 |
| Pathogen resistance | 7 | 5.3% | 0 | 0 |
| Acute generalised exanthematous pustulosis | 6 | 4.6% | 0 | 3 |
| Acute kidney injury | 6 | 4.6% | 0 | 4 |
| Headache | 6 | 4.6% | 0 | 0 |
| Rash | 6 | 4.6% | 0 | 3 |
| Toxic epidermal necrolysis | 6 | 4.6% | 0 | 6 |
| Delirium | 5 | 3.8% | 0 | 4 |
| Focal segmental glomerulosclerosis | 5 | 3.8% | 0 | 3 |
| Treatment failure | 5 | 3.8% | 0 | 1 |
Other Indications for GRISEOFULVIN
Product used for unknown indication (28)
Dermatophytosis (17)
Onychomycosis (12)
Trichophytosis (11)
Tinea cruris (8)
Tinea infection (8)
Body tinea (5)